BBVA USA Bancshares’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-6,985
Closed -$510K 515
2015
Q2
$510K Hold
6,985
0.03% 351
2015
Q1
$457K Hold
6,985
0.02% 410
2014
Q4
$454K Sell
6,985
-25
-0.4% -$1.61K 0.02% 412
2014
Q3
$422K Buy
7,010
+25
+0.4% +$1.63K 0.02% 420
2014
Q2
$484K Hold
6,985
0.02% 394
2014
Q1
$457K Hold
6,985
0.02% 393
2013
Q4
$433K Sell
6,985
-4,204
-38% -$243K 0.02% 395
2013
Q3
$600K Sell
11,189
-814
-7% -$41.9K 0.03% 302
2013
Q2
$548K Buy
+12,003
New +$520K 0.03% 303

Other funds holding STJ

BBVA USA Bancshares's STJ Position: Q3 2015 in Review

BBVA USA Bancshares sold out of St Jude Medical (STJ) in Q3 2015, closing a stake of 6,985 shares — an estimated $510K sold.

BBVA USA Bancshares first reported a position in STJ in Q2 2013 and held it in 9 quarters. The position peaked at $600K in Q3 2013. 618 funds tracked by Wall St. Rank hold STJ as of Q3 2015.

  • BBVA USA Bancshares reported no remaining St Jude Medical position as of Q3 2015 after selling out during the quarter.
  • BBVA USA Bancshares sold 6,985 St Jude Medical shares in Q3 2015, an estimated $510K.
  • BBVA USA Bancshares first reported a position in St Jude Medical in Q2 2013 and held it in 9 quarters.
  • BBVA USA Bancshares's St Jude Medical position peaked at $600K in Q3 2013.
  • 618 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2015.

Based on BBVA USA Bancshares's 13F filing for Q3 2015, filed 3 Nov 2015.